千金药业：2025年度业绩快报公告

Group 1 - The company announced a projected total operating revenue of 3,634,578,070.78 yuan for 2025, representing a year-on-year growth of 0.13% [2] - The net profit attributable to shareholders of the listed company is expected to be 287,836,838.39 yuan, showing a year-on-year increase of 24.74% [2]